iS Clinical Eclipse SPF 50
$50.00
In Stock
This antioxidant-rich blend provides superior water-resistant broad spectrum UVA/UVB protection. IS Clinical PerfecTint Eclipse SPF 50+ is an ultra sheer, lightweight formula that absorbs quickly for a non-greasy matte finish.
ULTRA SHEER, BROAD SPECTRUM, TINTED, SPF 50+
Volume: 103mL or 3.5oz
Key Ingredients:
- Titanium Dioxide (Transparent) 5.2%
- Zinc Oxide (Micronized) 1.1%
- Tocopherol (Vitamin E) 1.0%
This product is acne-safe.
Description
Formulated specifically for daily use and extended outdoor activities, iS Clinical Eclipse SPF 50+ is a unique fusion of scientifically advanced physical sunscreens – transparent Titanium Dioxide and micronized Zinc Oxide – coupled with pure Vitamin E. This antioxidant-rich blend provides superior water-resistant broad spectrum UVA/UVB protection. Eclipse SPF 50+ is an ultra sheer, lightweight formula that absorbs quickly for a non-greasy matte finish.
Application:
Apply liberally 15 minutes before sun exposure. Reapply: After 40 minutes of swimming or sweating, immediately after towel drying, and at least every 2 hours.
Benefits:
- Provides all-physical broad spectrum UVA/UVB protection
- PerfecTint® technology enriches natural skin tones
- Ultra-sheer, fast absorbing with a weightless finish
- Water resistant
Active ingredients: Titanium Dioxide 5.20%, Zinc Oxide 1.10%
Inactive ingredients: Water, C12-15 Alkyl Benzoate, Caprylic/Capric Triglyceride, Butylene Glycol, Octyldodecyl Neopentanoate, Cetearyl Glucoside, Cetearyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Polyhydroxystearic Acid, Alumina, Methicone, Triethoxycaprylylsilane, Tocopherol, VP/Eicosene Copolymer, Styrene/Acrylates Copolymer, Sorbitan Laurate, Tocopheryl Acetate, Xanthan Gum, 1,2-Hexanediol, Caprylyl Glycol, Disodium EDTA, Iron Oxides* (CI 77491*, CI 77492*, CI 77499*).
*may contain one or more of these ingredients
Additional information
Tint | Translucent, Tinted |
---|
Brand
iSClinical
You must be logged in to post a review.
Reviews
There are no reviews yet.